These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8427954)

  • 21. Rabbit blood coagulation factor XI. Mechanism of activation of rabbit Hageman factor (factor XII).
    Wiggins RC; Cochrane CG; Griffin JH
    Thromb Res; 1979; 15(3-4):487-95. PubMed ID: 494157
    [No Abstract]   [Full Text] [Related]  

  • 22. A new sensitive assay for bovine activated factor XI (factor XIa) using a reconstituted coagulation cascade system.
    Kato H; Nakagaki T; Morita T; Kisiel W; Iwanaga S
    Thromb Res; 1987 Nov; 48(4):461-74. PubMed ID: 3502201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombin activates factor XI on activated platelets in the absence of factor XII.
    Oliver JA; Monroe DM; Roberts HR; Hoffman M
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):170-7. PubMed ID: 9888880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis.
    von dem Borne PA; Meijers JC; Bouma BN
    Blood; 1995 Oct; 86(8):3035-42. PubMed ID: 7579397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen.
    Mandle RJ; Kaplan AP
    Blood; 1979 Oct; 54(4):850-62. PubMed ID: 89876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The soluble recombinant form of a binding protein/receptor for the globular domain of C1q (gC1qR) enhances blood coagulation.
    Peerschke EI; Jesty J; Reid KB; Ghebrehiwet B
    Blood Coagul Fibrinolysis; 1998 Jan; 9(1):29-37. PubMed ID: 9607116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I.
    Shi T; Iverson GM; Qi JC; Cockerill KA; Linnik MD; Konecny P; Krilis SA
    Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3939-44. PubMed ID: 15007174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional characterization of an abnormal factor XII molecule (F XII Bern).
    Wuillemin WA; Huber I; Furlan M; Lämmle B
    Blood; 1991 Aug; 78(4):997-1004. PubMed ID: 1868256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of charged groups in factor XI/XIa activity.
    Morgan K; Schiffman S
    J Biol Chem; 1982 Oct; 257(19):11284-7. PubMed ID: 6981645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate.
    Scott CF; Pixley RA; Colman RW
    Thromb Res; 1987 Dec; 48(6):685-700. PubMed ID: 3501619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
    Griffin JH; Cochrane CG
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmin-mediated activation of contact system in response to pharmacological thrombolysis.
    Ewald GA; Eisenberg PR
    Circulation; 1995 Jan; 91(1):28-36. PubMed ID: 7805216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The possible role of platelets in bypassing the contact phase of blood coagulation.
    Walsh PN; Tuszynski GP; Greengard JS; Griffin JH
    Haematologia (Budap); 1984; 17(2):169-78. PubMed ID: 6534825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI.
    Sinha D; Seaman FS; Koshy A; Knight LC; Walsh PN
    J Clin Invest; 1984 Jun; 73(6):1550-6. PubMed ID: 6609936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma.
    Wuillemin WA; Furlan M; Stricker H; Lämmle B
    Thromb Haemost; 1992 Feb; 67(2):219-25. PubMed ID: 1621242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact-initiated coagulation.
    MacQuarrie JL; Stafford AR; Yau JW; Leslie BA; Vu TT; Fredenburgh JC; Weitz JI
    Blood; 2011 Apr; 117(15):4134-41. PubMed ID: 21304106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human factor XIa cleaves fibrinogen: effects on structure and function.
    Scott CF; Mentzer RL; Budzynski AZ; Colman RW
    Arch Biochem Biophys; 1986 Sep; 249(2):480-8. PubMed ID: 2944482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surface activation of blood coagulation, fibrinolysis and kinin formation.
    Heimark RL; Kurachi K; Fujikawa K; Davie EW
    Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.